Literature DB >> 24555201

Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS mice.

Christian S Lobsiger, Don W Cleveland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24555201      PMCID： PMC3890793          DOI： 10.1073/pnas.1321606111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Role for terminal complement activation in amyotrophic lateral sclerosis disease progression.

Authors:  Trent M Woodruff; John D Lee; Peter G Noakes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-31       Impact factor: 11.205

2.  C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.

Authors:  Christian S Lobsiger; Severine Boillée; Christine Pozniak; Amir M Khan; Melissa McAlonis-Downes; Joseph W Lewcock; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

3.  Generation of C5a in the absence of C3: a new complement activation pathway.

Authors:  Markus Huber-Lang; J Vidya Sarma; Firas S Zetoune; Daniel Rittirsch; Thomas A Neff; Stephanie R McGuire; John D Lambris; Roscoe L Warner; Michael A Flierl; Laszlo M Hoesel; Florian Gebhard; John G Younger; Scott M Drouin; Rick A Wetsel; Peter A Ward
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

Review 4.  The complement system.

Authors:  J Vidya Sarma; Peter A Ward
Journal:  Cell Tissue Res       Date:  2010-09-14       Impact factor: 5.249

5.  Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  John D Lee; Nur A Kamaruzaman; Jenny N T Fung; Stephen M Taylor; Bradley J Turner; Julie D Atkin; Trent M Woodruff; Peter G Noakes
Journal:  J Neuroinflammation       Date:  2013-09-26       Impact factor: 8.322
  5 in total
  2 in total

Review 1.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

2.  Complement activation at the motor end-plates in amyotrophic lateral sclerosis.

Authors:  Nawal Bahia El Idrissi; Sanne Bosch; Valeria Ramaglia; Eleonora Aronica; Frank Baas; Dirk Troost
Journal:  J Neuroinflammation       Date:  2016-04-07       Impact factor: 8.322
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.